Mice lacking the calcineurin inhibitor Rcan2 have an isolated defect of osteoblast function

Endocrinology

Volumn 153, Issue 7, 2012, Pages 3537-3548

  Bassett, J H Duncan ^a   Logan, John G ^a   Boyde, Alan ^b   Cheung, Moira S ^a   Evans, Holly ^c   Croucher, Peter ^c,d   Sun, Xiao Yang ^e   Xu, Sai ^e   Murata, Yoshiharu ^e   Williams, Graham R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; LIOTHYRONINE RECEPTOR; REGULATOR OF CALCINEURIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL FUNCTION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE RESORPTION; CALCINEURIN; GENES, DOMINANT; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUTATION; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; X-RAY MICROTOMOGRAPHY;

EID: 84862729919     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1814     Document Type: Article

References (45)

1. Kingsbury TJ, Cunningham KW 2000 A conserved family of calcineurin regulators. Genes Dev 14:1595-1604 (Pubitemid 30460909)
2. Davies KJ, Ermak G, Rothermel BA, Pritchard M, Heitman J, Ahnn J, Henrique-Silva F, Crawford D, Canaider S, Strippoli P, Carinci P, Min KT, Fox DS, Cunningham KW, Bassel-Duby R, Olson EN, Zhang Z, Williams RS, Gerber HP, Pérez-Riba M, Seo H, Cao X, Klee CB, Redondo JM, Maltais LJ, Bruford EA, Povey S, Molkentin JD, McKeon FD, Duh EJ, Crabtree GR, Cyert MS, de la Luna S, Estivill X 2007 Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J 21:3023-3028 (Pubitemid 47565558)
3. Klee CB, Crouch TH, Krinks MH 1979 Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci USA 76:6270-6273 (Pubitemid 10163382)
4. Crabtree GR 1999 Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96:611-614
5. Stern PH 2006 The calcineurin-NFAT pathway and bone: intriguing new findings. Mol Interv 6:193-196 (Pubitemid 44455200)
6. Fuentes JJ, Genescà L, Kingsbury TJ, Cunningham KW, Pérez-Riba M, Estivill X, de la Luna S 2000 DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681-1690 (Pubitemid 30427005)
7. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS 2000 A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275:8719-8725 (Pubitemid 30180224)
8. Takayanagi H 2007 The role of NFAT in osteoclast formation. Ann NY Acad Sci 1116:227-237
9. Sun L, Blair HC, Peng Y, Zaidi N, Adebanjo OA, Wu XB, Wu XY, Iqbal J, Epstein S, Abe E, Moonga BS, Zaidi M 2005 Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci USA 102:17130-17135 (Pubitemid 41692695)
10. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H 2005 NFAT and Osterix cooperatively regulate bone formation. Nat Med 11:880-885 (Pubitemid 41161121)
11. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR 2006 Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10:771-782 (Pubitemid 43779111)
12. Yeo H, Beck LH, Thompson SR, Farach-Carson MC, McDonald JM, Clemens TL, Zayzafoon M 2007 Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. J Biol Chem 282:35318-35327 (Pubitemid 350232486)
13. Yeo H, Beck LH, McDonald JM, Zayzafoon M 2007 Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. Bone 40:1502-1516 (Pubitemid 46766648)
14. Epstein S, Shane E, Bilezikian JP 1995 Organ transplantation and osteoporosis. Curr Opin Rheumatol 7:255-261
15. Miyazaki T, Kanou Y, Murata Y, Ohmori S, Niwa T, Maeda K, Yamamura H, Seo H 1996 Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts. J Biol Chem 271:14567-14571 (Pubitemid 26190362)
16. Cao X, Kambe F, Miyazaki T, Sarkar D, Ohmori S, Seo H 2002 Novel human ZAKI-4 isoforms: hormonal and tissue-specific regulation and function as calcineurin inhibitors. Biochem J 367:459-466 (Pubitemid 35216820)
17. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H 2005 Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19:102-112 (Pubitemid 40065962)
18. Siddiq A, Miyazaki T, Takagishi Y, Kanou Y, Hayasaka S, Inouye M, Seo H, Murata Y 2001 Expression of ZAKI-4 messenger ribonucleic acid in the brain during rat development and the effect of hypothyroidism. Endocrinology 142:1752-1759 (Pubitemid 32405930)
19. Mizuno Y, Kanou Y, Rogatcheva M, Imai T, Refetoff S, Seo H, Murata Y 2004 Genomic organization of mouse ZAKI-4 gene that encodes ZAKI-4 α and β isoforms, endogenous calcineurin inhibitors, and changes in the expression of these isoforms by thyroid hormone in adult mouse brain and heart. Eur J Endocrinol 150:371-380 (Pubitemid 38443789)
20. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, Williams RS 2000 Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87:E61-E68
21. Bassett JH, Williams GR 2009 The skeletal phenotypes of TRα and TRβ mutant mice. J Mol Endocrinol 42:269-282
22. Sun XY, Hayashi Y, Xu S, Kanou Y, Takagishi Y, Tang YP, Murata Y 2011 Inactivation of the Rcan2 gene in mice ameliorates the age- and diet-induced obesity by causing a reduction in food intake. PLoS One 6:e14605
23. O'Shea PJ, Bassett JH, Sriskantharajah S, Ying H, Cheng SY, Williams GR 2005 Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor α1 or β. Mol Endocrinol 19:3045-3059 (Pubitemid 41697720)
24. O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR 2003 A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol 17:1410-1424 (Pubitemid 36819960)
25. Bassett JH, Nordström K, Boyde A, Howell PG, Kelly S, Vennström B, Williams GR 2007 Thyroid status during skeletal development determines adult bone structure and mineralization. Mol Endocrinol 21:1893-1904 (Pubitemid 47173799)
26. Bassett JH, O'Shea PJ, Sriskantharajah S, Rabier B, Boyde A, Howell PG, Weiss RE, Roux JP, Malaval L, Clement-Lacroix P, Samarut J, Chassande O, Williams GR 2007 Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol 21:1095-1107 (Pubitemid 46984761)
27. Bassett JH, Williams AJ, Murphy E, Boyde A, Howell PG, Swinhoe R, Archanco M, Flamant F, Samarut J, Costagliola S, Vassart G, Weiss RE, Refetoff S, Williams GR 2008 Alack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol 22:501-512 (Pubitemid 351185945)
28. Bassett JH, Boyde A, Howell PG, Bassett RH, Galliford TM, Archanco M, Evans H, Lawson MA, Croucher P, St Germain DL, Galton VA, Williams GR 2010 Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci USA 107:7604-7609
29. Dai XM, Zong XH, Akhter MP, Stanley ER 2004 Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J Bone Miner Res 19:1441-1451 (Pubitemid 41094345)
30. Schriefer JL, Robling AG, Warden SJ, Fournier AJ, Mason JJ, Turner CH 2005 A comparison of mechanical properties derived from multiple skeletal sites in mice. J Biomech 38:467-475 (Pubitemid 40126457)
31. Silva MJ, Brodt MD, Uthgenannt BA 2004 Morphological and mechanical properties of caudal vertebrae in the SAMP6 mouse model of senile osteoporosis. Bone 35:425-431 (Pubitemid 38953189)
32. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P 2002 High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233 (Pubitemid 34857841)
33. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K 1998 Impaired osteoclastic bone resorption leads to osteoporosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453-13458 (Pubitemid 28522993)
34. Boyde A, Firth EC 2005 Musculoskeletal responses of 2-year-old Thoroughbred horses to early training. 8. Quantitative back-scattered electron scanning electron microscopy and confocal fluorescence microscopy of the epiphysis of the third metacarpal bone. N Z Vet J 53:123-132 (Pubitemid 40529348)
35. Boyde A, Jones SJ, Aerssens J, Dequeker J 1995 Mineral density quantitation of the human cortical iliac crest by backscattered electron image analysis: variations with age, sex, and degree of osteoarthritis. Bone 16:619-627
36. Boyde A, Travers R, Glorieux FH, Jones SJ 1999 The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int 64:185-190 (Pubitemid 29107233)
37. Doube M, Firth EC, Boyde A 2007 Variations in articular calcified cartilage by site and exercise in the 18-month-old equine distal metacarpal condyle. Osteoarthritis Cartilage 15:1283-1292 (Pubitemid 350029037)
38. Bassett JH, Swinhoe R, Chassande O, Samarut J, Williams GR 2006 Thyroid hormone regulates heparin sulfate proteoglycan expression in the growth plate. Endocrinology 147:295-305 (Pubitemid 43004283)
39. Williams GR 2000 Cloning and characterization of two novel thyroid hormone receptor β isoforms. Mol Cell Biol 20:8329-8342
40. O'Shea PJ, Bassett JHD, Cheng SY, Williams GR 2006 Characterization of skeletal phenotypes of TRα1PV and TRßPV mutant mice: implications for tissue thyroid status and T3 target gene expression. Nuclear Receptor Signaling 4:e011 (http://www.nursa.org/article.cfm?doi=010.1621/nrs.04011)
41. Bala Y, Farlay D, Delmas PD, Meunier PJ, Boivin G 2010 Time sequence of secondary mineralization and microhardness in cortical and cancellous bone from ewes. Bone 46:1204-1212
42. Boivin G, Farlay D, Bala Y, Doublier A, Meunier PJ, Delmas PD 2009 Influence of remodeling on the mineralization of bone tissue. Osteoporos Int 20:1023-1026
43. Bassett JH, Williams GR 2008 Critical role of the hypothalamic-pituitary- thyroid axis in bone. Bone 43:418-426
44. Murphy E, Williams GR 2004 The thyroid and the skeleton. Clin Endocrinol (Oxf) 61:285-298 (Pubitemid 39287057)
45. Williams AJ, Robson H, Kester MH, van Leeuwen JP, Shalet SM, Visser TJ, Williams GR 2008 Iodothyronine deiodinase enzyme activities in bone. Bone 43:126-134